Thursday, October 29, 2009

Expo at BioWest 2009 Showcases New Technology, Products and Services for the Region’s Robust Bioscience Industry

More than 40 exhibitors will be showcasing new technology, products and services for 700+ attendees at the 2009 BioWest Conference and Expo. The announcement is made by John Collar, President and CEO of the Colorado BioScience Association (CBSA), who says the event is November 10 at the Grand Hyatt Denver, 1750 Welton.

“The companies participating in the exhibit area are each playing an important role in helping advance the bioscience industry within the region,” Collar said, “We’re very pleased to welcome them to our seventh annual BioWest event and are looking forward to yet another exciting and successful conference.”

BioWest is the Rocky Mountain region’s preferred venue for visiting and learning about the bioscience industry. Exhibitors confirmed to date include:

Biologics Consulting Group, Inc.,
Canadian Consulate,
CARE Research, Inc.,
CGL - Concert Group Logistics,
Colorado Science + Technology Park at Fitzsimons,
Compliant Logistics,
Concrete Floor Systems,
Colorado Prevention Center,
CRB Engineers & Builders,
Colorado State University Research Foundation,
Diablo Sales and Marketing,
Evergreen Research, Inc.,
Extronex Inc.,
GEL Analytics, LLC,
HemoGenix, Inc.,
Howe Creative,
ISEC, Inc.,
Jefferson Economic Council,
Keystone Symposia on Molecular and Cellular Biology,
LABS Inc.,
Leeds Precision Instruments,
Leo A Daly,
Quest Product Development,
Reglera, LLC,
Sheridan Ross P.C.,
TDC Medical, Inc.,
Technology Driven Products,
The Jackson Laboratory,
The Neenan Company,
Ubiquity Group,
University of Colorado Tech Transfer Office,
We Work for Health,
YSI, Inc.,

There is still exhibit space available for the Expo on a first-come, first-served basis. Contact Leah Kientz at 303-592-4088 if you are interested in being part of the 2009 Expo. Conference registration is required in order to view the Exhibitor Hall area. Complete registration details for the BioWest Conference and Expo are available at

CCIA Smart Grid Session 2 - Technical Challenges Ahead

Link to the video of the keynote by Dave Markham, Lockheed Martin, at the CCIA's Smart Grid session 2: Technical Challenges Ahead held yesterday (10/28/09) at the Denver Chamber.

Additional panel participants included: Dr. Frank Barnes, CU/Boulder; David Cohen, Infotility; and Marcia Martin, Magpie.

Dave Markham's remarks are available in three parts at the CCIA YouTube channel.

Sunday, October 25, 2009

Baxa Corp. moves headquarters into Maroon V building

"Medical-device manufacturer Baxa Corp. has agreed to lease the Maroon V office building for its new corporate headquarters. . . Developed by Shea Properties, Maroon V is a 4-story, Class A office building in the Meridian International Business Center, near Centennial Airport."

Friday, October 23, 2009

Real deals: Baxa moving to Meridian office park

Denver-area medical device maker Baxa Corp. is moving its headquarters to the Maroon V office building in the southeast suburban Meridian office park, the company said Friday.

The relocation will consolidate Baxa’s executive and administrative operations, which are now in three separate locations. Baxa expects to move into its new space in May 2010.

Baxa recently signed an agreement to lease 64,000 square feet at 88,584-square-foot Maroon V, which is located at 9540 S. Maroon Circle in Douglas County, with an Englewood mailing address. The lease is one of the southeastern suburbs’ largest new leases of the year so far, according to the company.

Baxa Corporation Signs Agreement for New Corporate Headquarters Facility

Baxa Corporation, a global manufacturer of medical devices for health-system pharmacies, announces it has signed an agreement to lease the Maroon V office building as its new corporate headquarters facility. The new facility will allow Baxa to consolidate its current executive and administrative operations –currently occupying three separate building spaces –into a single facility of approximately 64,000 square feet. The move also accommodates the planned expansion of the company’s production capacity at its Grasslands facility to support business growth.

Maroon V is a 4-story, Class A office building in the Meridian International Business Center, south of Denver, Colorado. Developed by Shea Properties, the LEED-certified building will provide a state-of-the-art working environment for Baxa executive officers, product development and laboratory testing; sales, marketing and technical support activities; and accounting and finance associates.

According to Dustin Whistler of Forte Commercial Real Estate, "This transaction represents one of the top real estate deals in the metro area this year. At the time of signature, this was the largest new lease signed in the submarket in 2009." Forte provided brokerage and transaction management services for this and previous Baxa Corporation real estate projects and assisted the company with site selection and assembly of the tenant’s external team of professionals.

Wednesday, October 21, 2009

BioWest 2009 Registration Opens, Rolling Out A Stellar Lineup of National Speakers

Peter Sims, co-author of best selling business book “True North” and the forthcoming book “Little Bets” will provide the keynote for the 2009 BioWest Conference and Expo. In addition to Sims, nationally acclaimed speakers Ginger Graham, former CEO of Amylin Pharmaceuticals, and Eric Alexander - skier, climber, and mountaineer - will address the BioWest audience during the November 10th event at the Grand Hyatt Denver.

Organizers expect more than 700 industry leaders November 10th for the seventh annual BioWest event, held again at the Grand Hyatt Denver, 1750 Welton.

Tuesday, October 20, 2009

Denver's Baxa Corp signs China marketing deal

"Colorado's Baxa Corp. said Monday it has reached a four-year distribution agreement with China's largest pharmaceutical-products distributor for sale of its products there. The Englewood-based medical device company signed the deal with Sinopharm Group.

The move into the China market comes after China's State Council recently allocated $123 billion for medical and health-care improvements, including medical technology, Baxa said."

Monday, October 19, 2009

Baxa agreement will help Chinese hospital pharmacies be more accurate, safe & efficient

Baxa Corporation, a US-based medical device company in Englewood, Colorado, has signed an exclusive four-year distribution agreement with SINOPHARM, a China National Pharmaceutical Foreign Trade Corporation, to promote sales of its products in China. While the agreement covers all Baxa products, the ExactaMix™ 2400 Automated Compounder and the Repeater™ Pharmacy Pump have been recognized as ones that will increase efficiency for the hospitals targeted by Baxa and SINOPHARM in the People’s Republic of China (PRC). Due to their existing practice of manual preparation, the companies expect that more than 250 hospitals could benefit from the Baxa pharmacy automation equipment.

The partners anticipate that Baxa Corporation’s expertise in automation could greatly improve the existing processes in Chinese hospitals – making their pharmacy operations more accurate, safe and efficient. “Baxa products are used all across the world every day by thousands of pharmacies. By entering the Chinese market, patients there will access the same outstanding quality that Baxa products have provided for 35 years in other parts of the world,” states Phil Walsh, Baxa Director of International Sales.

Wednesday, October 14, 2009

Baxa Announces IntelliFlowRx™ to Become DoseEdge™ Dose Management System

Baxa Corporation announces the rebranding of its IntelliFlowRx Workload Management Software to DoseEdge. The name DoseEdge (pronounced “dosage”) was chosen to reinforce the product’s leading edge position in pharmacy dose management. DoseEdge streamlines the previously manual workflow for pharmacy doses through barcode drug verification; automatic dose calculation; image capture of dose creation and improving pharmacist checking activity.
“IntelliFlow Rx was originally designed for IV room workflow management,” notes Tim Kingsford, DoseEdge Product Manager. “With the launch of the new brand name DoseEdge, we are expanding the system’s capabilities beyond the IV room for more complete dose management within the health-system pharmacy.”

Tuesday, October 13, 2009

Colorado Girl Scouts: Denver Women of Distinction Honors Rae Ann Dougherty

The annual Women of Distinction program is widely regarded as the one of Denver’s premier philanthropic programs, bringing together and recognizing a group of purpose-driven leaders, women in business, government and philanthropic communities; who, like the girls, are dedicated to service and leadership. My good friend Rae Ann Dougherty was one of the honorees this year.

Link to more information about the program

Link to Rae Ann's Bio at R&R Strategies

Denver Business Journal: CBSA pushes education initiatives to help attract future workers

"Biology teacher Tammy Hearty enjoyed going 'back to school' this past summer.
Better yet, she’s happy she didn’t blow up anything during her stint in the laboratory at OSI Pharmaceuticals in Boulder.

Hearty, who teaches honors biology at Fairview High School in Boulder, was part of a Colorado BioScience Association (CBSA) program that connects teachers with local businesses to help them learn about their subject matter from the inside."

Baucus’ tax idea worrying makers of medical devices

Federal excise taxes on medical device sales have been proposed to help fund health care reform, prompting industry worries the $4 billion in annual fees will stifle innovation and eliminate jobs.It’s a chief concern among Colorado manufacturers — who employ nearly 11,000 people in the state — though they support reform.

John Collar, CEO and president of the Colorado BioScience Association (CBSA) trade group, flew to Washington, D.C., at the end of September to tell Sens. Mark Udall and Michael Bennet that the industry sees the fees proposed in Sen. Max Baucus’ leading bill as a potential disaster.

Friday, October 09, 2009

Denver-based Cosmetic Acupuncture Expert Dr. Martha Lucas Conducts Intensive Seminar Sessions for Physicians in Istanbul

Denver-based Cosmetic Acupuncture specialist and author Martha Lucas, Ph.D., L.Ac., has recently returned from a teaching tour of Istanbul. The announcement is made by Dr. Lucas, who says “The interest in safe, natural, non-invasive cosmetic procedures simply spans the globe now. MDs in Turkey are trained in acupuncture but don’t have the specialty training like I offer in cosmetic protocols.”

Wednesday, October 07, 2009

Delegation Touts Colorado's Med Device & Diagnostics Strengths at AdvaMed in D.C.

For three days, representatives from the Colorado BioScience Association (CBSA), Colorado Office of Economic Development and International Trade, Metro Denver Economic Development Corporation and the Greater Colorado Springs Economic Development Corporation will be showcasing Colorado’s medical device and diagnostics sectors during the annual AdvaMed: The MedTech Conference. The announcement is made by John Collar, CBSA Executive Director, who says more than 1,400 industry leaders – including 500+ CEOs, Presidents and C-level executives will be attending the AdvaMed: The MedTech Conference, October 12-14.

Tuesday, October 06, 2009

Inviragen Merges with SingVax and Completes $15 million Series A Financing

Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for infectious diseases prevalent in emerging economies. Concurrently with the merger, the combined company raised $15 million in a Series A equity investment from a syndicate of international venture capital investors, including Charter Life Sciences (Palo Alto, CA), Venture Investors (Madison, WI), Bio*One Capital (Singapore) and Phillip Private Equity (Singapore).

The combined company will retain the Inviragen name and will have research and corporate operations in Fort Collins, Colorado, vaccine development operations in Singapore and vaccine testing capabilities in Madison, Wisconsin. “Post-merger, Inviragen has three vaccines poised to begin human clinical trials,” noted Dr. Dan Stinchcomb, Inviragen Chief Executive Officer. “During the next 18 months, these clinical studies will test vaccine safety and measure the immune responses induced by these three vaccines to establish 'proof-of-concept' of their efficacy.”

Smart Grid Session 1 Video Recaps Now Available at the CCIA YouTube Channel

The CCIA held the first of three sessions on Smart Grid, September 30, 2009. Video recaps are now available of the first session at the CCIA's YouTube Channel:

Link to the CCIA YouTube Channel